Uddhav Thackeray launches world's largest convalescent plasma project

Maharashtra Chief Minister Uddhav Thackeray addresses on coronavirus crisis, in Mumbai on Sunday.

Maharashtra Chief Minister Uddhav

Thackeray on Monday launched convalescent plasma therapy-cum- trial project for treatment of critical COVID-19 patients with a state medical education department official calling it the largest initiative of its kind in the world.

Convalescent plasma therapy, also called passive antibody therapy, seeks to obtain plasma from the blood of people who have recovered from the infection to inject into patients undergoing treatment.

"The project, titled 'Platina', is the largest convalescent plasma therapy-cum-trial project in the world. With it, we intend to save lives of some 500 critical COVID-19 patients. The trial will be held in 17 medical colleges under the department of medical education and drugs, and four BMC- run colleges in Mumbai," the official said.

All critical patients will receive two doses of 200 ml convalescent plasma free of cost, he added.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel